Tapewire

Nasdaq · USD

BTAI

BioXcel Therapeutics, Inc.

Export transactions ↓
Tapewire entity
8380
SEC CIK
0001720893
Parsed reports
276

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 31, 2025 Filed Feb 4, 2025 22:28 UTC Exercise / conversionRestricted Stock Units · Derivative 27,089 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-009204 · tm255496-1_4seq1.xml · derivative · entry 2

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,810

Underlying: Common Stock · 27,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

F2 · derivative.expiration_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:28 UTC Exercise / conversionCommon Stock 27,089 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-009204 · tm255496-1_4seq1.xml · nonDerivative · entry 1

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 15, 2025 Filed Jan 16, 2025 08:04 UTC
Patni RajivDirector
GrantStock Option (right to buy) · Derivative 44,000 $0.00 Strike: $0.35 $0.00
Disclosure

SEC source: 0001104659-25-003952 · tm252892-2_4seq1.xml · derivative · entry 1

Patni Rajiv · CIK 0001616200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2035-01-15

F1 · derivative.exercise_date: On January 15, 2025, the Reporting Person was granted an option to purchase 44,000 shares of common stock, which vests in three equal installments on the first three anniversaries of the grant date, subject to his continued service as a Director through the vesting period.

Read SEC document
January 07, 2025 Filed Jan 11, 2025 01:03 UTC
Mehta VimalDirector · CEO and President · 10% owner
GrantStock Option (right to buy) · Derivative 660,000 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001104659-25-002693 · tm252892-4_4seq1.xml · derivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 660,000

Underlying: Common Stock · 660,000 shares

Expires 2035-01-07

F1 · derivative.exercise_date: On January 7, 2025, the Reporting Person was granted an option to purchase 660,000 shares of common stock, which vests in twelve equal monthly installments over a twelve-month period following the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
January 07, 2025 Filed Jan 11, 2025 01:00 UTC
Steinhart Richard IChief Financial Officer
GrantStock Option (right to buy) · Derivative 270,000 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001104659-25-002689 · tm252892-3_4seq1.xml · derivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2035-01-07

F1 · derivative.exercise_date: On January 7, 2025, the Reporting Person was granted an option to purchase 270,000 shares of common stock, which vests in twelve equal monthly installments over a twelve-month period following the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
January 07, 2025 Filed Jan 11, 2025 01:01 UTC
Yocca FrankChief Scientific Officer
GrantStock Option (right to buy) · Derivative 270,000 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001104659-25-002691 · tm252892-5_4seq1.xml · derivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2035-01-07

F1 · derivative.exercise_date: On January 7, 2025, the Reporting Person was granted an option to purchase 270,000 shares of common stock, which vests in twelve equal monthly installments over a twelve-month period following the grant date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:05 UTC Exercise / conversionRestricted Stock Units · Derivative 27,089 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000782 · tm251731-1_4seq1.xml · derivative · entry 2

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,899

Underlying: Common Stock · 27,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

F2 · derivative.expiration_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 21:05 UTC Exercise / conversionCommon Stock 27,089 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-000782 · tm251731-1_4seq1.xml · nonDerivative · entry 1

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
SaleCommon Stock 2,134 $0.36 $773.36
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · nonDerivative · entry 4

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,605

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The Reporting Person undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
SaleCommon Stock 983 $0.36 $357.91
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · nonDerivative · entry 3

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,920

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The Reporting Person undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 18:10 UTC
O'Neill VincentSee Remarks
SaleCommon Stock 165 $0.35 $58.13
Disclosure

SEC source: 0001104659-24-129464 · tm2431371-5_4seq1.xml · nonDerivative · entry 2

O'Neill Vincent · CIK 0001672718 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,957

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
SaleCommon Stock 372 $0.36 $133.18
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · nonDerivative · entry 4

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,932

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
SaleCommon Stock 205 $0.36 $73.80
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · nonDerivative · entry 3

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,157

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
SaleCommon Stock 220 $0.36 $78.47
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · nonDerivative · entry 4

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,423

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
SaleCommon Stock 210 $0.36 $74.55
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · nonDerivative · entry 3

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,643

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
SaleCommon Stock 225 $0.35 $79.02
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · nonDerivative · entry 4

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,931

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
SaleCommon Stock 205 $0.36 $72.80
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · nonDerivative · entry 3

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,156

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2023.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
Exercise / conversionRestricted Stock Units · Derivative 3,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · derivative · entry 8

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,500

Underlying: Common Stock · 3,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: On March 15, 2023, the Reporting Person was granted 56,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F6 · derivative.expiration_date: On March 15, 2023, the Reporting Person was granted 56,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
Exercise / conversionCommon Stock 3,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · nonDerivative · entry 2

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 562 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · derivative · entry 6

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,064

Underlying: Common Stock · 562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F4 · derivative.expiration_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
Exercise / conversionCommon Stock 562 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · nonDerivative · entry 2

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 562 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · derivative · entry 6

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,064

Underlying: Common Stock · 562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F4 · derivative.expiration_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
Exercise / conversionCommon Stock 562 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · nonDerivative · entry 2

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 562 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · derivative · entry 6

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,064

Underlying: Common Stock · 562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F4 · derivative.expiration_date: On March 15, 2023, the Reporting Person was granted 9,000 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
Exercise / conversionCommon Stock 562 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · nonDerivative · entry 2

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
Exercise / conversionRestricted Stock Units · Derivative 2,610 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · derivative · entry 7

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,049

Underlying: Common Stock · 2,610 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F5 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:08 UTC
Mehta VimalDirector · CEO and President · 10% owner
Exercise / conversionCommon Stock 2,610 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129462 · tm2431371-4_4seq1.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO and President · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 18:10 UTC
O'Neill VincentSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 521 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129464 · tm2431371-5_4seq1.xml · derivative · entry 3

O'Neill Vincent · CIK 0001672718 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,606

Underlying: Common Stock · 521 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 18:10 UTC
O'Neill VincentSee Remarks
Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129464 · tm2431371-5_4seq1.xml · nonDerivative · entry 1

O'Neill Vincent · CIK 0001672718 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 521 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · derivative · entry 5

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,606

Underlying: Common Stock · 521 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:06 UTC
Steinhart Richard IChief Financial Officer
Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129461 · tm2431371-3_4seq1.xml · nonDerivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 521 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · derivative · entry 5

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,606

Underlying: Common Stock · 521 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:04 UTC
Rodriguez JavierSee Remarks
Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129458 · tm2431371-2_4seq1.xml · nonDerivative · entry 1

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,291

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 521 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · derivative · entry 5

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,606

Underlying: Common Stock · 521 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
December 14, 2024 Filed Dec 17, 2024 23:03 UTC
Yocca FrankChief Scientific Officer
Exercise / conversionCommon Stock 521 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-129457 · tm2431371-1_4seq1.xml · nonDerivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 30, 2024 Filed Dec 3, 2024 21:05 UTC Exercise / conversionCommon Stock 27,089 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-125073 · tm2430075-1_4seq1.xml · nonDerivative · entry 1

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 30, 2024 Filed Dec 4, 2024 21:05 UTC Amendment Exercise / conversionRestricted Stock Units · Derivative 27,089 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-125506 · tm2430194-1_4aseq1.xml · derivative · entry 2

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 297,988

Underlying: Common Stock · 27,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

F2 · derivative.expiration_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

Read SEC document
November 30, 2024 Filed Dec 4, 2024 21:05 UTC Amendment Exercise / conversionCommon Stock 27,089 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-125506 · tm2430194-1_4aseq1.xml · nonDerivative · entry 1

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:06 UTC GrantRestricted Stock Units · Derivative 325,077 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-122570 · tm2429407-2_4seq1.xml · derivative · entry 1

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,077

Underlying: Common Stock · 325,077 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

F2 · derivative.expiration_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

Read SEC document
November 21, 2024 Filed Dec 3, 2024 21:05 UTC GrantRestricted Stock Units · Derivative 297,988 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-125073 · tm2430075-1_4seq1.xml · derivative · entry 2

MACK DAVID J. · CIK 0001694466 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 297,998

Underlying: Common Stock · 297,988 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

F2 · derivative.expiration_date: On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.

Read SEC document
October 03, 2024 Filed Oct 3, 2024 21:53 UTC
O'Neill VincentSee Remarks
SaleCommon Stock 5,556 $0.55 $3,055.80
Disclosure

SEC source: 0001104659-24-106060 · tm2425607-1_4seq1.xml · nonDerivative · entry 2

O'Neill Vincent · CIK 0001672718 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,601

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5500 to $0.5501. The Reporting Person undertakes to provide upon request the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 01:54 UTC
Steinhart Richard IChief Financial Officer
SaleCommon Stock 7,175 $0.55 $3,946.25
Disclosure

SEC source: 0001104659-24-106061 · tm2425607-2_4seq1.xml · nonDerivative · entry 2

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,279

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5500 to $0.5515. The Reporting Person undertakes to provide upon request the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 01:55 UTC
Wiley Matthew T.Chief Commercial Officer
SaleCommon Stock 6,272 $0.55 $3,449.60
Disclosure

SEC source: 0001104659-24-106064 · tm2425607-7_4seq1.xml · nonDerivative · entry 2

Wiley Matthew T. · CIK 0001759703 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,011

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 01:55 UTC
Rodriguez JavierSee Remarks
SaleCommon Stock 6,863 $0.55 $3,774.65
Disclosure

SEC source: 0001104659-24-106063 · tm2425607-6_4seq1.xml · nonDerivative · entry 2

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,770

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5500 to $0.5515. The Reporting Person undertakes to provide upon request the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
October 03, 2024 Filed Oct 4, 2024 01:54 UTC
Yocca FrankChief Scientific Officer
SaleCommon Stock 7,175 $0.55 $3,946.25
Disclosure

SEC source: 0001104659-24-106062 · tm2425607-3_4seq1.xml · nonDerivative · entry 2

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,278

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.5500 to $0.5501. The Reporting Person undertakes to provide upon request the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Read SEC document
September 17, 2024 Filed Oct 3, 2024 21:53 UTC
O'Neill VincentSee Remarks
GrantCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-106060 · tm2425607-1_4seq1.xml · nonDerivative · entry 1

O'Neill Vincent · CIK 0001672718 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,157

F1 · price: The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.

Read SEC document
September 17, 2024 Filed Oct 4, 2024 01:54 UTC
Steinhart Richard IChief Financial Officer
GrantCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-106061 · tm2425607-2_4seq1.xml · nonDerivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,454

F1 · price: The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.

Read SEC document
September 17, 2024 Filed Oct 4, 2024 01:55 UTC
Wiley Matthew T.Chief Commercial Officer
GrantCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-106064 · tm2425607-7_4seq1.xml · nonDerivative · entry 1

Wiley Matthew T. · CIK 0001759703 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,283

F1 · price: The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.

Read SEC document
September 17, 2024 Filed Oct 4, 2024 01:55 UTC
Rodriguez JavierSee Remarks
GrantCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-106063 · tm2425607-6_4seq1.xml · nonDerivative · entry 1

Rodriguez Javier · CIK 0001847919 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,633

F1 · price: The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.

Read SEC document
September 17, 2024 Filed Oct 4, 2024 01:54 UTC
Yocca FrankChief Scientific Officer
GrantCommon Stock 21,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-106062 · tm2425607-3_4seq1.xml · nonDerivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,453

F1 · price: The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through October 1, 2024 (the "PSUs"). On September 17, 2024, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 21,250 PSUs had been satisfied and 21,250 shares of common stock became issuable to the Reporting Person on October 1, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.